Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review.

ABSTRACT:

Background

National targets for timely diagnosis and management of a potential cancer are driven in part by the perceived risk of disease progression during avoidable delays. However, it is unclear to what extent time-to-treatment impacts prognosis for patients with non-small cell lung cancer, with previous reviews reporting mixed or apparently paradoxical associations. This systematic review focuses on potential confounders in order to identify particular patient groups which may benefit most from timely delivery of care.

Methods

Medline, EMBASE and Cochrane databases were searched for publications between January 2012 and October 2020, correlating timeliness in secondary care pathways to patient outcomes. The protocol is registered with PROSPERO (the International Prospect

SUBMITTER: Hall H 

PROVIDER: S-EPMC9340041 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature